Publications

Jarick KJ, Topczewska PM, Jakob MO, Yano H, Arifuzzaman M, Gao X, Boulekou S, Stokic-Trtica V, Leclère PS, Preußer A et al..  2022.  Non-redundant functions of group 2 innate lymphoid cells.. Nature. 611(7937):794-800.

Jarick KJ, Topczewska PM, Jakob MO, Yano H, Arifuzzaman M, Gao X, Boulekou S, Stokic-Trtica V, Leclère PS, Preußer A et al..  2022.  Non-redundant functions of group 2 innate lymphoid cells.. Nature. 611(7937):794-800.

Chen K, Chen J, Smith E, Mathani P, Longman R, Lukin D, Scherl E, Gerber J, Battat R.  2022.  Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn's Disease.. Inflamm Bowel Dis.

Chen K, Chen J, Smith E, Mathani P, Longman R, Lukin D, Scherl E, Gerber J, Battat R.  2022.  Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn's Disease.. Inflamm Bowel Dis.

Mantel I, Sadiq BA, J Blander M.  2022.  Spotlight on TAP and its vital role in antigen presentation and cross-presentation.. Mol Immunol. 142:105-119.

Pan Y, Ahmed W, Mahtani P, Wong R, Longman R, Lukin DJeremy, Scherl EJ, Battat R.  2022.  Utility of Therapeutic Drug Monitoring for Tumor Necrosis Factor Antagonists and Ustekinumab in Postoperative Crohn's Disease.. Inflamm Bowel Dis. 28(12):1865-1871.

Zhou W, Zhou L, Zhou J, Chu C, Zhang C, Sockolow RE, Eberl G, Sonnenberg GF.  2022.  ZBTB46 defines and regulates ILC3s that protect the intestine.. Nature. 609(7925):159-165.

Zhou W, Zhou L, Zhou J, Chu C, Zhang C, Sockolow RE, Eberl G, Sonnenberg GF.  2022.  ZBTB46 defines and regulates ILC3s that protect the intestine.. Nature. 609(7925):159-165.

Hill AA, Kim M, Zegarra-Ruiz DF, Chang L-C, Norwood K, Assié A, Wu W-JH, Renfroe MC, Song HWong, Major AM et al..  2023.  Acute high-fat diet impairs macrophage-supported intestinal damage resolution.. JCI Insight. 8(3)

Hill AA, Kim M, Zegarra-Ruiz DF, Chang L-C, Norwood K, Assié A, Wu W-JH, Renfroe MC, Song HWong, Major AM et al..  2023.  Acute high-fat diet impairs macrophage-supported intestinal damage resolution.. JCI Insight. 8(3)

Park SL, Christo SN, Wells AC, Gandolfo LC, Zaid A, Alexandre YO, Burn TN, Schröder J, Collins N, Han S-J et al..  2023.  Divergent molecular networks program functionally distinct CD8+ skin-resident memory T cells.. Science. 382(6674):1073-1079.

Park SL, Christo SN, Wells AC, Gandolfo LC, Zaid A, Alexandre YO, Burn TN, Schröder J, Collins N, Han S-J et al..  2023.  Divergent molecular networks program functionally distinct CD8+ skin-resident memory T cells.. Science. 382(6674):1073-1079.

Wheeler MA, Clark IC, Lee H-G, Li Z, Linnerbauer M, Rone JM, Blain M, Akl CFaust, Piester G, Giovannoni F et al..  2023.  Droplet-based forward genetic screening of astrocyte-microglia cross-talk.. Science. 379(6636):1023-1030.

Wheeler MA, Clark IC, Lee H-G, Li Z, Linnerbauer M, Rone JM, Blain M, Akl CFaust, Piester G, Giovannoni F et al..  2023.  Droplet-based forward genetic screening of astrocyte-microglia cross-talk.. Science. 379(6636):1023-1030.

Abramson J, Dobeš J, Lyu M, Sonnenberg GF.  2023.  The emerging family of RORγt+ antigen-presenting cells.. Nat Rev Immunol.

Ma Y, Sannino D, Linden JR, Haigh S, Zhao B, Grigg JB, Zumbo P, Dündar F, Butler D, Profaci CP et al..  2023.  Epsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege.. J Clin Invest. 133(9)

Ma Y, Sannino D, Linden JR, Haigh S, Zhao B, Grigg JB, Zumbo P, Dündar F, Butler D, Profaci CP et al..  2023.  Epsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege.. J Clin Invest. 133(9)

Sargsian S, Lejeune A, Ercelen D, Jin W-B, Varghese A, Loke P'ng, Lim YAL, Guo C-J, Cadwell K.  2023.  Functional characterization of helminth-associated Clostridiales reveals covariates of Treg differentiation.. bioRxiv.

Topczewska PM, Rompe ZA, Jakob MO, Stamm A, Leclère PS, Preußer A, Duerr CU, Thole LMarie Laur, Kotsch K, Artis D et al..  2023.  ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses.. Front Immunol. 14:1130933.

Rajan A, Pan Y, Mahtani P, Niec R, Longman R, Gerber J, Lukin D, Scherl E, Battat R.  2023.  The Impact of Confounders on Symptom-Endoscopic Discordances in Crohn's Disease.. Crohns Colitis 360. 5(2):otad017.

Awasthi D, Chopra S, Cho BA, Emmanuelli A, Sandoval TA, Hwang S-M, Chae C-S, Salvagno C, Tan C, Vasquez-Urbina L et al..  2023.  Inflammatory ER stress responses dictate the immunopathogenic progression of systemic candidiasis.. J Clin Invest. 133(17)

Awasthi D, Chopra S, Cho BA, Emmanuelli A, Sandoval TA, Hwang S-M, Chae C-S, Salvagno C, Tan C, Vasquez-Urbina L et al..  2023.  Inflammatory ER stress responses dictate the immunopathogenic progression of systemic candidiasis.. J Clin Invest. 133(17)

Awasthi D, Chopra S, Cho BA, Emmanuelli A, Sandoval TA, Hwang S-M, Chae C-S, Salvagno C, Tan C, Vasquez-Urbina L et al..  2023.  Inflammatory ER stress responses dictate the immunopathogenic progression of systemic candidiasis.. J Clin Invest. 133(17)

Sei S, Ahadova A, Keskin DB, Bohaumilitzky L, Gebert J, Doeberitz Mvon Knebel, Lipkin SM, Kloor M.  2023.  Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies.. Front Oncol. 13:1147590.

Han S-J, Stacy A, Corral D, Link VM, De Siqueira MKrystel, Chi L, Teijeiro A, Yong DS, P Perez-Chaparro J, Bouladoux N et al..  2023.  Microbiota configuration determines nutritional immune optimization.. Proc Natl Acad Sci U S A. 120(49):e2304905120.